AU2001277539A1 - Pre-adipose cell lines - Google Patents

Pre-adipose cell lines

Info

Publication number
AU2001277539A1
AU2001277539A1 AU2001277539A AU7753901A AU2001277539A1 AU 2001277539 A1 AU2001277539 A1 AU 2001277539A1 AU 2001277539 A AU2001277539 A AU 2001277539A AU 7753901 A AU7753901 A AU 7753901A AU 2001277539 A1 AU2001277539 A1 AU 2001277539A1
Authority
AU
Australia
Prior art keywords
immortalized
cell lines
cells
adipose
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001277539A
Inventor
Christian Darimont
Katherine Mace
Andrea Pfeifer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of AU2001277539A1 publication Critical patent/AU2001277539A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

This invention relates to new immortalized human pre-adipose cell lines capable of differentiating into adipose cells and methods of obtaing the immortalized cells. In particular, the present invention pertains to immortalized pre-adipocyte cell lines derived from white adipose tissue and methods of producing the cell lines. The immortalized pre-adipocyte cells are capable of maturing into immortalized white adipose cells useful in developing drugs, food ingredients and supplements against obesity, diabetes and cardiovascular diseases.
AU2001277539A 2000-07-18 2001-07-13 Pre-adipose cell lines Abandoned AU2001277539A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00115489 2000-07-18
EP00115489 2000-07-18
PCT/EP2001/008165 WO2002006450A1 (en) 2000-07-18 2001-07-13 Pre-adipose cell lines

Publications (1)

Publication Number Publication Date
AU2001277539A1 true AU2001277539A1 (en) 2002-01-30

Family

ID=8169292

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001277539A Abandoned AU2001277539A1 (en) 2000-07-18 2001-07-13 Pre-adipose cell lines

Country Status (8)

Country Link
US (1) US7294509B2 (en)
EP (1) EP1303589B1 (en)
JP (1) JP2004504024A (en)
CN (1) CN100595274C (en)
AT (1) ATE373082T1 (en)
AU (1) AU2001277539A1 (en)
DE (1) DE60130464T2 (en)
WO (1) WO2002006450A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003228356A1 (en) * 2002-03-22 2003-10-13 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for preventing obesity and obesity related disorders
US20050136039A1 (en) * 2002-03-22 2005-06-23 Joslin Diabetes Center, Inc. Adipocytes and uses thereof
AU2003242459B2 (en) * 2002-06-18 2007-05-17 Eisai R&D Management Co., Ltd. Primary cultured adipocytes for gene therapy
US20090317367A1 (en) * 2007-02-21 2009-12-24 Cedars-Sinai Medical Center Methods of producing preadipocytes and increasing the proliferation of adult adipose stem/progenitor cells
CN101259266B (en) * 2008-04-14 2010-04-14 山东大学 Preadipocyte heterologous vaccine and preparation method and application thereof
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
CN102140437A (en) * 2011-01-07 2011-08-03 西北农林科技大学 Culturing method for quickly dedifferentiating porcine mature fat cell into precursor fat cell
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
KR101422559B1 (en) 2012-03-09 2014-07-24 창원대학교 산학협력단 Culture medium of adipose-derived stem cell, method for preparing the same, and composition for promoting hair growth comprising the same
CN102876717B (en) * 2012-10-29 2014-06-11 东北农业大学 Method for building immortalized preadipocytes of chicken
ES2957410T3 (en) * 2013-04-19 2024-01-18 Biorestorative Therapies Inc Stem cells derived from human brown adipose tissue and their uses
US20150037436A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US10428316B2 (en) * 2014-12-04 2019-10-01 Intervet Inc. Immortalised chicken embryo fibroblasts
US10531957B2 (en) 2015-05-21 2020-01-14 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
WO2017094260A1 (en) * 2015-12-01 2017-06-08 学校法人 慶應義塾 Method for manufacturing mesenchymal cell line derived from vertebrate animal adipose tissue
EP3387113A1 (en) * 2015-12-11 2018-10-17 Intervet International B.V. Immortalised chicken embryonic epithelial kidney cells
EP3739323A4 (en) 2018-01-24 2021-03-17 Sniper (Beijing) Medical Technologies Co., Ltd Microdroplet container, method for preparing microdroplet container, microdroplet spreading method, microdroplet formation kit, temperature control device, oil phase composition for microdroplet formation and treatment method therefor
US11666900B2 (en) 2018-01-24 2023-06-06 Sniper (Suzhou) Life Technology Co. Motion controlling mechanism, liquid discharging nozzle, microdroplet generating device and method, liquid driving mechanism and method, microdroplet generating method, and surface processing method of liquid discharging nozzle
CN110064443B (en) * 2018-01-24 2021-07-30 思纳福(北京)医疗科技有限公司 Micro-droplet tiling method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830682A (en) * 1994-09-09 1998-11-03 Zymogenetics Preparation of immortalized cells
FR2733513B1 (en) * 1995-04-25 1997-07-18 Centre Nat Rech Scient IMMORTALIZED LINES OF CELLS FROM HUMAN FATTY TISSUE, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS
US5827740A (en) * 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
JP5055611B2 (en) * 1998-09-09 2012-10-24 学校法人日本大学 Preadipocyte cell line
WO2000024866A2 (en) * 1998-10-26 2000-05-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Multipotential human medullary stromal cell line of and uses thereof

Also Published As

Publication number Publication date
JP2004504024A (en) 2004-02-12
EP1303589A1 (en) 2003-04-23
EP1303589B1 (en) 2007-09-12
DE60130464T2 (en) 2008-06-12
US7294509B2 (en) 2007-11-13
CN100595274C (en) 2010-03-24
CN1458973A (en) 2003-11-26
DE60130464D1 (en) 2007-10-25
WO2002006450A1 (en) 2002-01-24
ATE373082T1 (en) 2007-09-15
US20030175957A1 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
AU2001277539A1 (en) Pre-adipose cell lines
HK1065447A1 (en) Stimulation of in vivo production of proteins withformulation comprising leucine
GB0001309D0 (en) Valve arrangement
EP1670450B8 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
MXPA03001898A (en) Materials and methods for the treatment or prevention of obesity.
BRPI0413241A (en) monatin table sweetener compositions and methods of making the same
DE60330781D1 (en) APPLICATION OF LACTOBACILLUS TO THE PREPARATION OF EXOPOLYSACCHARIDES IN FOOD AND PHARMACEUTICAL COMPOSITIONS
DE602004030823D1 (en) METHOD AND SYSTEM FOR PRODUCING STRAIN CELLS FROM FAT TISSUE
AU2001254624A1 (en) Human coagulation factor vii variants
TW200513534A (en) Methods and compositions for the differentiation of human preadipocytes into adipocytes
WO2002092756A3 (en) Insulin producing cells derived from human embryonic stem cells
WO2004007695A3 (en) Lactobacilli expressing biologically active polypeptides and uses thereof
DE69931907D1 (en) HAGA BUTTER COMPOSITIONS AS AN ANTI-INFLAMMABLE NATURAL MEDICAMENT TO FACILITATE / REDUCE SYMPTOMS RELATING TO INFLAMMATION AND ARTHRITIS
TW200719908A (en) Dermatologic use of milk proteins
WO2014191056A1 (en) Combination of active agents for treating skin aging
WO2004054558A3 (en) Reduction of breast density with 4-hydroxy tamoxifen
AU2002338852A1 (en) Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease
HK1039729A1 (en) Method for providing glutamine.
AU2003235874A1 (en) Skin collagen production promoter
AU2002336417A1 (en) Methods of generating human cd4+ th1 cells
ES2168845T3 (en) COSMETIC COMPOSITION CONTAINING AN ACTIVE COMPONENT ABLE TO STIMULATE "IN VIVO" THE PRODUCTION OF INTERLEUQUINE 6 (IL-6) BY HUMAN KERATINOCITS.
AU2018278219A1 (en) Methods for producing feather-based food products
DE602005010256D1 (en) PRODUCT OF VEGETABLE ORIGIN CONTAINING PROANTHOCYANE, AND METHOD FOR ITS MANUFACTURE
HUP9902421A2 (en) Medicament for optimising mucosal viscosity and stimulating intestinal function
WO2002081521A3 (en) Osteoprotegerin in milk